HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Epithelial ovarian cancers (EOCs) often exhibit morphologic features of embryonic Müllerian duct-derived tissue lineages and colonize peritoneal surfaces that overlie connective and adipose tissues. However, the mechanisms that enable EOC cells to readily adapt to the peritoneal environment are poorly understood. In this study, we show that expression of HOXA9, a Müllerian-patterning gene, is strongly associated with poor outcomes in patients with EOC and in mouse xenograft models of EOC. Whereas HOXA9 promoted EOC growth in vivo, HOXA9 did not stimulate autonomous tumor cell growth in vitro. On the other hand, expression of HOXA9 in EOC cells induced normal peritoneal fibroblasts to express markers of cancer-associated fibroblasts (CAFs) and to stimulate growth of EOC and endothelial cells. Similarly, expression of HOXA9 in EOC cells induced normal adipose- and bone marrow-derived mesenchymal stem cells (MSCs) to acquire features of CAFs. These effects of HOXA9 were due in substantial part to its transcriptional activation of the gene encoding TGF-β2 that acted in a paracrine manner on peritoneal fibroblasts and MSCs to induce CXCL12, IL-6, and VEGF-A expression. These results indicate that HOXA9 expression in EOC cells promotes a microenvironment that is permissive for tumor growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Secretion of elevated levels of IL-6 by MSC has been detected upon interaction with malignant cells in several epithelial, hematopoietic and mesenchymal cancers (Table 2) [43, 69, 76, 77, 82, 115–119].”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [69]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516 · cited 2×
“Overexpression of Hoxa9 in primary bone marrow cells enhances hematopoietic stem cell regeneration, expands the myeloid progenitor pool, and collaborates with Meis1a to induce AML in mice (52, 53).”
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931 · cited 1×
“Because TGF-β signaling induces EMT in many cell types (31), CAFs in +HOXA9 tumors might also derive from tumor cells.”
Human Adipose Tissue Is a Source of Multipotent Stem Cells
Zuk, P. A., Zhu, M., Ashjian, P., De Ugarte, D. A., Huang, J. I., Mizuno, H., Alfonso, Z. C., Fraser, J. K., Benhaim, P., & Hedrick, M. H. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-02-0105 · Cited by 6,664 · cited 2×
“Bone marrow is the most well-characterized source of MSCs, but MSCs reside in most tissues and are abundant in white adipose tissues (23, 24).”
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538 · cited 11×
“A similar difference in FAP induction was also observed (Supplemental Figure 7B).”
InfluentialOrimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Mesenchymal stem cells reside in virtually all post-natal organs and tissues
Meirelles, L. D. S., Chagastelles, P. C., & Nardi, N. B. (2006) · Journal of Cell Science · doi:10.1242/jcs.02932 · Cited by 2,485 · cited 1×
“Bone marrow is the most well-characterized source of MSCs, but MSCs reside in most tissues and are abundant in white adipose tissues (23, 24).”
Ovarian Cancer Development and Metastasis
Lengyel, E. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100105 · Cited by 1,672 · cited 3×
“However, since progression of EOC is driven by multiple autocrine and paracrine mechanisms (1, 2), we cannot exclude the possibility that HOXA9 also promotes progression of this disease by stimulating other signaling pathways in tumor or host cells.”
Self-citationNovel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
Tothill, R. W., Tinker, A. V., George, J., Brown, R., Fox, S. B., Lade, S., Johnson, D. S., Trivett, M. K., Etemadmoghadam, D., Locandro, B., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0196 · Cited by 1,467 · cited 3×
“Tothill et al. classified tumors in the AOCS cohort into molecular subtypes by their gene expression signatures (19).”
InfluentialSanford, L. P., Ormsby, I., Groot, A. C. G.-D., Sariola, H., Friedman, R., Boivin, G. P., Cardell, E. L., & Doetschman, T. (1997) · Development · doi:10.1242/dev.124.13.2659 · Cited by 1,447
Stenderup, K. (2003) · Bone · doi:10.1016/j.bone.2003.07.005 · Cited by 1,206
Quante, M., Tu, S. P., Tomita, H., Gonda, T., Wang, S. S. W., Takashi, S., Baik, G. H., Shibata, W., DiPrete, B., Betz, K. S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.020 · Cited by 1,044 · cited 3×
“CAFs are a source of various mitogenic factors for tumor cells (15, 17).”
TUMOR STROMA AND REGULATION OF CANCER DEVELOPMENT
Tlsty, T. D., & Coussens, L. M. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100224 · Cited by 987 · cited 3×
“As is the case in normal organogenesis, it is increasingly recognized that tumor growth is orchestrated by dynamic interactions between epithelial and stromal cells (12, 13).”
Betaglycan presents ligand to the TGFβ signaling receptor
López-Casillas, F., Wrana, J. L., & Massagué, J. (1993) · Cell · doi:10.1016/0092-8674(93)90368-z · Cited by 901 · cited 1×
“Whereas TGF-β 1 and TGF-β 3 bind to T β RII with high affinity, TGF-β 2 requires the accessory molecule betaglycan to facilitate receptor binding (32).”
Modulating Hox gene functions during animal body patterning
Pearson, J. C., Lemons, D., & McGinnis, W. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1726 · Cited by 879
Kojima, Y., Acar, A., Eaton, E. N., Mellody, K. T., Scheel, C., Ben-Porath, I., Onder, T. T., Wang, Z. C., Richardson, A. L., Weinberg, R. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013805107 · Cited by 848 · cited 6×
“Acquisition of a TGF-β autocrine signaling loop in resident mammary fibroblasts has been reported to drive transition of these cells into CAFs (18), but a mechanism for initiation of this loop was not identified.”
InfluentialSpaeth, E. L., Dembinski, J. L., Sasser, A. K., Watson, K., Klopp, A., Hall, B., Andreeff, M., & Marini, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004992 · Cited by 807 · cited 1×
“MSCs are another potential source of CAFs in many types of tumors, including EOC (14, 16, 17, 22).”
Self-citationPelton, R. W., Saxena, B., Jones, M., Moses, H. L., & Gold, L. I. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.4.1091 · Cited by 670
Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b
Kroon, E., Krosl, J., Thorsteinsdottir, U., Baban, S., Buchberg, A. M., & Sauvageau, G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.13.3714 · Cited by 640 · cited 1×
“Overexpression of Hoxa9 in primary bone marrow cells enhances hematopoietic stem cell regeneration, expands the myeloid progenitor pool, and collaborates with Meis1a to induce AML in mice (52, 53).”
Deregulated homeobox gene expression in cancer: cause or consequence?
Abate-Shen, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc907 · Cited by 617 · cited 1×
“Although many homeobox genes are aberrantly expressed in tumors, their mechanisms in tumorigenesis are poorly understood and only a few bona fide transcriptional target genes have been identified (5–7).”
Ovarian Cancer Metastasis: Integrating insights from disparate model organisms
Naora, H., & Montell, D. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1611 · Cited by 538 · cited 1×
“EOC cells typically shed into the peritoneal fluid and implant on the mesothelial linings of the omentum and other peritoneal surfaces that overlie connective and white adipose tissues (1, 2).”
Self-citationBone marrow contribution to tumor-associated myofibroblasts and fibroblasts
Direkze, N. C., Hodivala-Dilke, K., Jeffery, R., Hunt, T., Poulsom, R., Oukrif, D., Alison, M. R., & Wright, N. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1708 · Cited by 530 · cited 4×
“Whereas the ability of CAFs to stimulate growth of tumor cells has been extensively studied (14–18), it is not clear whether CAFs are reciprocally controlled by developmental programs that are activated in tumor cells.”
InfluentialBenson, G. V., Lim, H., Paria, B. C., Satokata, I., Dey, S. K., & Maas, R. L. (1996) · Development · doi:10.1242/dev.122.9.2687 · Cited by 501
Taylor, H. S., Arici, A., Olive, D., & Igarashi, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1057 · Cited by 484
Taylor, H. S., Vanden Heuvel, G. B., & Igarashi, P. (1997) · Biology of Reproduction · doi:10.1095/biolreprod57.6.1338 · Cited by 463 · cited 2×
“Patterning of the Müllerian system is coordinated by members of the HOXA gene cluster (8–10).”
Carson, D. D. (2002) · Molecular Human Reproduction · doi:10.1093/molehr/8.9.871 · Cited by 437 · cited 1×
“Whereas HOXA10 and HOXA11 are upregulated in the endometrium during luteal phase, HOXA9 is downregulated (48–50), implicating a function of HOXA9 in proliferative control in the Müllerian system.”
Taylor, H. S., Arici, A., Olive, D., & Igarashi, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1597 · Cited by 419 · cited 1×
“Whereas HOXA10 and HOXA11 are upregulated in the endometrium during luteal phase, HOXA9 is downregulated (48–50), implicating a function of HOXA9 in proliferative control in the Müllerian system.”
Hoxa 11 structure, extensive antisense transcription, and function in male and female fertility
Hsieh-Li, H. M., Witte, D. P., Weinstein, M., Branford, W., Li, H., Small, K., & Potter, S. S. (1995) · Development · doi:10.1242/dev.121.5.1373 · Cited by 393
McLean, K., Gong, Y., Choi, Y., Deng, N., Yang, K., Bai, S., Cabrera, L., Keller, E., McCauley, L., Cho, K. R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45273 · Cited by 380
Nemunaitis, J., Dillman, R. O., Schwarzenberger, P. O., Senzer, N., Cunningham, C., Cutler, J., Tong, A., Kumar, P., Pappen, B., Hamilton, C., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.5335 · Cited by 367 · cited 1×
“Anti–TGF-β2 therapies have been developed to circumvent immunosuppression in patients with cancer (30).”
Thorsteinsdottir, U., Mamo, A., Kroon, E., Jerome, L., Bijl, J., Lawrence, H. J., Humphries, K., & Sauvageau, G. (2002) · Blood · doi:10.1182/blood.v99.1.121 · Cited by 347
Cheng, W., Liu, J., Yoshida, H., Rosen, D., & Naora, H. (2005) · Nature Medicine · doi:10.1038/nm1230 · Cited by 305
Self-citationEpithelial to Mesenchymal Transition in Human Breast Cancer Can Provide a Nonmalignant Stroma
Petersen, O. W., Nielsen, H. L., Gudjonsson, T., Villadsen, R., Rank, F., Niebuhr, E., Bissell, M. J., & Rønnov-Jessen, L. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63834-5 · Cited by 305 · cited 7×
“It is thus unlikely that CAFs in +HOXA9 tumors derive substantially from tumor cells that undergo EMT in response to induction of TGF-β 2 by HOXA9.”
InfluentialA PANorama of PAX genes in cancer and development
Robson, E. J. D., He, S.-J., & Eccles, M. R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1778 · Cited by 283 · cited 3×
“Homeobox genes encode transcription factors, but only few bona fide transcriptional targets have been identified (4–7).”
Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival
Muratovska, A., Zhou, C., He, S., Goodyer, P., & Eccles, M. R. (2003) · Oncogene · doi:10.1038/sj.onc.1206766 · Cited by 248 · cited 1×
“However, many of the homeobox genes studied to date alter tumor cell proliferation or survival in vitro (38–40), implying that these genes modulate tumor growth via tumor cell-autonomous mechanisms.”
Kenny, H. A., Krausz, T., Yamada, S. D., & Lengyel, E. (2007) · International Journal of Cancer · doi:10.1002/ijc.22874 · Cited by 243 · cited 1×
“previously described (57), with informed patient consent.”
Self-citationZhang, Y., Tang, H., Cai, J., Zhang, T., Guo, J., Feng, D., & Wang, Z. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.01.011 · Cited by 242 · cited 2×
“Normal cells expressing CAF markers have been detected in omental tissues of patients with EOC without overt omental metastasis (21).”
Bascom, C. C., Wolfshohl, J. R., Coffey, R. J., Madisen, L., Webb, N. R., Purchio, A. R., Derynck, R., & Moses, H. L. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.12.5508 · Cited by 215
The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1
Coletta, R. D., Christensen, K., Reichenberger, K. J., Lamb, J., Micomonaco, D., Huang, L., Wolf, D. M., Müller-Tidow, C., Golub, T. R., Kawakami, K., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401139101 · Cited by 213
Homeobox gene expression in cancer: Insights from developmental regulation and deregulation
Samuel, S., & Naora, H. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.014 · Cited by 188
Self-citationDirect Regulation of β3-Integrin Subunit Gene Expression by HOXA10 in Endometrial Cells
Daftary, G. S., Troy, P. J., Bagot, C. N., Young, S. L., & Taylor, H. S. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.3.0792 · Cited by 169 · cited 1×
“HOXA10 induces expression of β 3-integrin, which increases ovarian epithelial cell proliferation by promoting direct contact with fibroblasts (44, 45), but HOXA10 and β 3-integrin also inhibit invasiveness (46, 47).”
Sex Steroids Mediate HOXA11 Expression in the Human Peri-Implantation Endometrium1
Taylor, H. S., Igarashi, P., Olive, D. L., & Arici, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5573 · Cited by 165
Yoshida, H., Broaddus, R. R., Cheng, W., Xie, S.-S., & Naora, H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2828 · Cited by 162 · cited 1×
“HOXA10 induces expression of β 3-integrin, which increases ovarian epithelial cell proliferation by promoting direct contact with fibroblasts (44, 45), but HOXA10 and β 3-integrin also inhibit invasiveness (46, 47).”
Self-citationWu, Q., Lothe, R. A., Ahlquist, T. C., Silins, I., Trope, C. G., Micci, F., Nesland, J. M., Suo, Z., & Lind, G. E. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-45 · Cited by 148
Langley, R. R., Ramirez, K. M., Tsan, R. Z., Arsdall, M. R. V., Nilsson, M. B., & Fidler, I. J. (2003) · PubMed · Cited by 144
Montavon, C., Gloss, B., Warton, K., Barton, C. A., Statham, A. L., Scurry, J., Tabor, B., Nguyen, T. V., Qu, W., Samimi, G., et al. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.11.026 · Cited by 127 · cited 10×
“However, CAFs might also be activated by other mechanisms, since not all EOCs express HOXA9 .”
InfluentialLoss of Betaglycan Expression in Ovarian Cancer: Role in Motility and Invasion
Hempel, N., How, T., Dong, M., Murphy, S. K., Fields, T. A., & Blobe, G. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0035 · Cited by 123 · cited 10×
“However, CAFs might also be activated by other mechanisms, since not all EOCs express HOXA9 .”
InfluentialHOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype
Gilbert, P. M., Mouw, J. K., Unger, M. A., Lakins, J. N., Gbegnon, M. K., Clemmer, V. B., Benezra, M., Licht, J. D., Boudreau, N. J., Tsai, K. K. C., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39534 · Cited by 122 · cited 1×
“Indeed, HOXA9 has been reported to be downregulated in breast and lung cancer cells and to have tumor-suppressive properties in these tumor cell types (55, 56).”
Atlas of Gynecologic Surgical Pathology
Clement, P. B., & Young, R. H. (2008) · Medical Entomology and Zoology · Cited by 114
Sex Steroids Mediate HOXA11 Expression in the Human Peri-Implantation Endometrium
Taylor, H. S. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.3.1129 · Cited by 83
Kaur, S., Kenny, H. A., Jagadeeswaran, S., Zillhardt, M., MONTAG, A. G., Kistner, E. O., Yamada, S. D., Mitra, A. K., & Lengyel, E. R. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090028 · Cited by 80
Self-citationLanger, J. C., Henckaerts, E., Orenstein, J., & Snoeck, H.-W. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20030980 · Cited by 73 · cited 1×
“Interestingly, TGF-β 2, like HOXA9, is preferentially expressed in primitive hematopoietic cells and stimulates the repopulating capacity of hematopoietic stem cells (54).”
Multipotent adipose stromal cells and breast cancer development: Think globally, act locally
Zhao, M., Dumur, C. I., Holt, S. E., Beckman, M. J., & Elmore, L. W. (2010) · Molecular Carcinogenesis · doi:10.1002/mc.20675 · Cited by 64 · cited 1×
“It is thought that CAFs derive from bone marrow MSCs at advanced stages of disease, whereas tissue-resident MSCs (and fibroblasts) are the predominant source of CAFs at early stages of tumor development (34).”
Son, J. W., Jeong, K. J., Jean, W.-S., Park, S. Y., Jheon, S., Cho, H. M., Park, C. G., Lee, H. Y., & Kang, J. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.06.021 · Cited by 58 · cited 1×
“Indeed, HOXA9 has been reported to be downregulated in breast and lung cancer cells and to have tumor-suppressive properties in these tumor cell types (55, 56).”
Hara, F., Samuel, S., Liu, J., Rosen, D. G., Langley, R. R., & Naora, H. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061025 · Cited by 57 · cited 1×
“Some homeobox genes promote angiogenesis by inducing expression of angiogenic factors or chemotactic factors for endothelial progenitor cells (36, 37).”
Self-citationHOXA3 Modulates Injury-Induced Mobilization and Recruitment of Bone Marrow-Derived Cells
Mace, K. A., Restivo, T. E., Rinn, J. L., Paquet, A. C., Chang, H. Y., Young, D. M., & Boudreau, N. J. (2009) · Stem Cells · doi:10.1002/stem.90 · Cited by 47 · cited 1×
“Some homeobox genes promote angiogenesis by inducing expression of angiogenic factors or chemotactic factors for endothelial progenitor cells (36, 37).”
Direct Regulation of 3-Integrin Subunit Gene Expression by HOXA10 in Endometrial Cells
Daftary, G. S. (2002) · Molecular Endocrinology · doi:10.1210/me.16.3.571 · Cited by 47
Transforming growth factor-β isoform expression in human ovarian tumours
Bartlett, J. M. S., Langdon, S. P., Scott, W. N., Love, S., Miller, E. P., Katsaros, D., Smyth, J. F., & Miller, W. R. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00304-3 · Cited by 45
Trinh, B. Q., Barengo, N., & Naora, H. (2011) · Oncogene · doi:10.1038/onc.2011.4 · Cited by 39
Self-citationAbendstein, B. J., Stadlmann, S., Knabbe, C., Buck, M. B., Müller‐Holzner, E., Zeimet, A. G., Marth, C., Obrist, P., Krugmann, J., & Offner, F. A. (2000) · Cytokine · doi:10.1006/cyto.1999.0632 · Cited by 33
Ko, S. Y., Lengyel, E. R., & Naora, H. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.12.025 · Cited by 22 · cited 1×
“HOXA10 induces expression of β 3-integrin, which increases ovarian epithelial cell proliferation by promoting direct contact with fibroblasts (44, 45), but HOXA10 and β 3-integrin also inhibit invasiveness (46, 47).”
Self-citationCorrelation Analysis of HOX, ErbB and IGFBP Family Gene Expression in Ovarian Cancer
Bahrani-Mostafavi, Z., Tickle, T. L., Zhang, J., Bennett, K., Vachris, J. C., Spencer, M., Mostafavi, M. T., & Tait, D. L. (2008) · Cancer Investigation · doi:10.1080/07357900802074349 · Cited by 20 · cited 1×
“HOXA9 expression has been detected in EOCs at a range of levels in 2 independent studies (11, 41) and also widely varies among patients with EOC in the AOCS and TCGA cohorts.”
Rupture of abdominal aneurysm into the gastrointestinal tract
Antzis, E., Dunn, J. T., & Schilero, A. J. (1951) · The American Journal of Medicine · doi:10.1016/0002-9343(51)90210-0 · Cited by 13
Research works printed but not linked: 1
- Langley, 2003, Cancer Res., 63, 2971
Cited by
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Wu, F., Yang, J., Liu, J., Wang, Y., Mu, J., Zeng, Q., Deng, S., & Zhou, H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00641-0 · Cited by 773
“In ovarian cancer through TGF-β signaling pathway, tumor-derived lysophosphatidic acid and exosomes promoted the differentiation of MSCs to CAFs, and cancer-derived TGF-β stimulated the expression of IL-6, C–X-C motif chemokine 12 (CXCL12), and VEGFA in CAFs to induce metastasis.(114) Accumulating evidence suggests th…”
BackgroundRegulatory circuits of T cell function in cancer
Speiser, D. E., Ho, P.-C., & Verdeil, G. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.80 · Cited by 566
Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum
Lee, W., Ko, S. Y., Mohamed, M. S., Kenny, H. A., Lengyel, E., & Naora, H. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181170 · Cited by 478
“ES2 cells that stably express tGFP have been previously described (Ko et al., 2012).”
BackgroundSelf-citationGuo, F., Wang, Y., Liu, J., Mok, S. C., Xue, F., & Zhang, W. (2016) · Oncogene · doi:10.1038/onc.2015.139 · Cited by 468
T Cell Dysfunction in Cancer Immunity and Immunotherapy
Xia, A., Zhang, Y., Xu, J., Yin, T., & Lu, X.-J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01719 · Cited by 341
“These molecules include IL-10, type I IFNs, IDO, adenosine, VEGF-A, TGF-β, and IL-35.”
BackgroundInfluential
Metadata
- Authors
- Ko, S. Y., Barengo, N., Ladanyi, A., Lee, J.-S., Marini, F., Lengyel, E., & Naora, H.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Wake Forest University (US)
- University of Chicago (US)
- Corresponding author
- Naora, Honami
- Venue
- Journal of Clinical Investigation
- Published
- 2012-10-01
- Volume
- 122
- Issue
- 10
- Pages
- 3603-3617
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3461910
- OpenAlex
- W1988224215
- Cited by
- 132
- References
- 62
- Citations by year
- 2025: 10 · 2024: 9 · 2023: 11 · 2022: 9 · 2021: 10 · 2020: 10 · 2019: 10 · 2018: 9 · 2017: 10 · 2016: 4 · 2015: 10 · 2014: 14 · 2013: 14 · 2012: 2
- FWCI
- 14.95
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (RP120390, 4r01ca111882-10)
- University of Texas MD Anderson Cancer Center
- National Cancer Institute (R01-CA111882, CA141078, CA101826, R01CA101826, R01CA141078, P30CA016672)
- Topics
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- HOXA9, epithelial ovarian cancer, cancer-associated fibroblasts, tumor microenvironment, Müllerian ducts, TGF-beta2, mesenchymal stem cells, adipose-derived stem cells, bone marrow-derived stem cells, CXCL12, interleukin-6, VEGF-A, paracrine signaling, tumor growth
- MeSH terms
- Adipose Tissue, Animals, Carcinoma, Cell Differentiation, Cell Division, Epithelial Cells, Female, Fibroblasts, Humans, Mice, Nude, Neoplasm Proteins, Ovarian Neoplasms, Peritoneal Neoplasms, Peritoneum, Prognosis, Tumor Cells, Cultured, Interleukin-6, Gene Expression Regulation, Neoplastic, Culture Media, Conditioned, Homeodomain Proteins, Paracrine Communication, Vascular Endothelial Growth Factor A, Endothelial Cells, Mice, Kaplan-Meier Estimate, Transforming Growth Factor beta2, Chemokine CXCL12, Tumor Microenvironment, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.